132 related articles for article (PubMed ID: 8000055)
21. Diagnostic Utility of Mean Peak Systolic Velocity of Superior Thyroid Artery in Differentiating Graves' Disease from Thyroiditis.
Sarangi PK; Parida S; Mangaraj S; Mohanty BK; Mohanty J; Swain BM
Indian J Radiol Imaging; 2021 Apr; 31(2):311-317. PubMed ID: 34556913
[No Abstract] [Full Text] [Related]
22. [The role of color doppler ultrasonography, thyroid function and auto antibody for the screening of Graves' disease in pregnancy].
Xue M; Shi QL; Tan KN; Wu Y; Zhou R
Zhonghua Nei Ke Za Zhi; 2016 Jun; 55(6):470-3. PubMed ID: 27256611
[TBL] [Abstract][Full Text] [Related]
23. [Ultrasonographic evaluation of thyroid tissue perfusion in patients with Graves-Basedow disease as preparation for surgery].
Rogula T; Cichoń S
Folia Med Cracov; 2000; 41(3-4):121-9. PubMed ID: 11339007
[TBL] [Abstract][Full Text] [Related]
24. Role of thyroid Doppler in differential diagnosis of thyrotoxicosis.
Hari Kumar KV; Pasupuleti V; Jayaraman M; Abhyuday V; Rayudu B R; Modi KD
Endocr Pract; 2009; 15(1):6-9. PubMed ID: 19211390
[TBL] [Abstract][Full Text] [Related]
25. Quantitative Color Doppler Ultrasonography Measurement of Thyroid Blood Flow in Patients with Graves' Disease.
Yuksekkaya R; Celikyay F; Gul SS; Yuksekkaya M; Kutluturk F; Ozmen C
Curr Med Imaging; 2020; 16(9):1111-1124. PubMed ID: 32107993
[TBL] [Abstract][Full Text] [Related]
26. [Duplex sonography in functional thyroid diagnosis].
Schweiger U; Hosten N; Cordes M; Lemke AJ; Rümpler W; Meng W; Felix R
Rofo; 1996 Feb; 164(2):114-8. PubMed ID: 8679972
[TBL] [Abstract][Full Text] [Related]
27. Effect of lugol solution on thyroid gland blood flow and microvessel density in the patients with Graves' disease.
Erbil Y; Ozluk Y; Giriş M; Salmaslioglu A; Issever H; Barbaros U; Kapran Y; Ozarmağan S; Tezelman S
J Clin Endocrinol Metab; 2007 Jun; 92(6):2182-9. PubMed ID: 17389702
[TBL] [Abstract][Full Text] [Related]
28. The value of color flow Doppler ultrasonography of the superior thyroid artery in the surgical management of Graves disease.
Huang SM; Chow NH; Lee HL; Wu TJ
Arch Surg; 2003 Feb; 138(2):146-51; discussion 151. PubMed ID: 12578408
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness and Mechanism of Preoperative Lugol Solution for Reducing Thyroid Blood Flow in Patients with Euthyroid Graves' Disease.
Huang SM; Liao WT; Lin CF; Sun HS; Chow NH
World J Surg; 2016 Mar; 40(3):505-9. PubMed ID: 26546192
[TBL] [Abstract][Full Text] [Related]
30. Thyroid ultrasound pattern in primary hypothyroidism is similar to Graves' disease: a report of three cases.
Ushakov AV
J Med Life; 2024 Jan; 17(1):116-122. PubMed ID: 38737666
[TBL] [Abstract][Full Text] [Related]
31. Hashimoto's thyroiditis following Graves' disease.
Umar H; Muallima N; Adam JM; Sanusi H
Acta Med Indones; 2010 Jan; 42(1):31-5. PubMed ID: 20305330
[TBL] [Abstract][Full Text] [Related]
32. Estimation of antithyroid drug dose in Graves' disease: value of quantification of thyroid blood flow with color duplex sonography.
Saleh A; Fürst G; Feldkamp J; Godehardt E; Grust A; Mödder U
Ultrasound Med Biol; 2001 Aug; 27(8):1137-41. PubMed ID: 11527601
[TBL] [Abstract][Full Text] [Related]
33. Role of color Doppler in differentiation of Graves' disease and thyroiditis in thyrotoxicosis.
Donkol RH; Nada AM; Boughattas S
World J Radiol; 2013 Apr; 5(4):178-83. PubMed ID: 23671754
[TBL] [Abstract][Full Text] [Related]
34. Differential autoantibody responses to thyroid peroxidase in patients with Graves' disease and Hashimoto's thyroiditis.
Bermann M; Magee M; Koenig RJ; Kaplan MM; Arscott P; Maastricht J; Johnson J; Baker JR
J Clin Endocrinol Metab; 1993 Oct; 77(4):1098-101. PubMed ID: 8408460
[TBL] [Abstract][Full Text] [Related]
35. Thyroid peroxidase activity-inhibiting immunoglobulins in patients with autoimmune thyroid disease.
Okamoto Y; Hamada N; Saito H; Ohno M; Noh J; Ito K; Morii H
J Clin Endocrinol Metab; 1989 Apr; 68(4):730-4. PubMed ID: 2921308
[TBL] [Abstract][Full Text] [Related]
36. Opposite changes in serum soluble CD8 in patients at the active stages of Graves' and Hashimoto's diseases.
Watanabe M; Amino N; Hochito K; Watanabe K; Kuma K; Iwatani Y
Thyroid; 1997 Oct; 7(5):743-7. PubMed ID: 9349577
[TBL] [Abstract][Full Text] [Related]
37. [Quantitative determination of echogenicity of diffuse inflammatory thyroid gland diseases].
Happ J; Cordes U; Jost-Köstering S; Puhahn M
Bildgebung; 1993 Sep; 60(3):131-4. PubMed ID: 8251734
[TBL] [Abstract][Full Text] [Related]
38. [Mean arterial blood flow depends on the intensity of thyrotoxicosis in patients with Graves' disease].
Czarkowski M; Hilgertner L; Powałowski T; Radomski D
Pol Merkur Lekarski; 2005 Jun; 18(108):667-70. PubMed ID: 16124380
[TBL] [Abstract][Full Text] [Related]
39. [Evaluation of the retrobulbar space in Graves' orbitopathy using color Doppler ultrasonography].
Cmelo J; Chynoranský M; Zvác J; Rybár M
Cesk Slov Oftalmol; 1997 May; 53(2):106-11. PubMed ID: 9296857
[TBL] [Abstract][Full Text] [Related]
40. The reproducibility of the virtual organ computer-aided analysis program for evaluating 3-dimensional power Doppler ultrasonography of diffuse thyroid disorders.
Chiou SC; Hsieh MH; Chen HY; Lin JD; Chen CC; Hsu WH; Jeng LB; Chang CT; Chen RH; Wang TY; Haung WL
J Endocrinol Invest; 2009 Feb; 32(2):139-46. PubMed ID: 19411812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
